Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke Trial
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
A multicentre, ambulance-delivered, prospective, randomized, open-label, blinded endpoint
(PROBE) study to assess the effects of hyperacute intensive blood pressure (BP) lowering
initiated in ambulance setting on (i) functional outcome in patients with acute stroke (ii)
safety in patients with confirmed acute stroke and other conditions that were initially
suspected as acute stroke (i.e. stroke mimic).
Phase:
Phase 3
Details
Lead Sponsor:
The George Institute for Global Health, China
Collaborators:
First Affiliated Hospital of Chengdu Medical College Shanghai East Hospital